"AN 2" Pill Images
The following drug pill images match your search criteria.

1 / 4
Loading
MYLAN 421

1 / 2
Loading
MYLAN 245

1 / 3
Loading
MYLAN 7025 MYLAN 7025
Loxapine Succinate
- Strength
- 25 mg
- Imprint
- MYLAN 7025 MYLAN 7025
- Color
- Green / Brown
- Shape
- Capsule/Oblong

MYLAN 2252 MYLAN 2252
Selegiline Hydrochloride
- Strength
- 5 mg
- Imprint
- MYLAN 2252 MYLAN 2252
- Color
- Blue
- Shape
- Capsule/Oblong
Featured

Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Reviews & ratings

1 / 2
Loading
logo Reliant 225

S SANDOZ 572
Amlodipine Besylate and Benazepril Hydrochloride
- Strength
- 5 mg / 10 mg
- Imprint
- S SANDOZ 572
- Color
- Brown
- Shape
- Capsule/Oblong

TOFRANIL-PM 125 mg M
Tofranil-PM
- Strength
- 125 mg
- Imprint
- TOFRANIL-PM 125 mg M
- Color
- Orange & White
- Shape
- Capsule/Oblong

ANCOBON 250 ICN ANCOBON 250 ICN
Ancobon
- Strength
- 250 mg
- Imprint
- ANCOBON 250 ICN ANCOBON 250 ICN
- Color
- Gray / Green
- Shape
- Capsule/Oblong

AAT 102 MYLAN
Amlodipine Besylate and Atorvastatin Calcium
- Strength
- 10 mg / 20 mg
- Imprint
- AAT 102 MYLAN
- Color
- Blue
- Shape
- Oval
MYLAN ZE 20 MYLAN ZE 20
Ziprasidone Hydrochloride
- Strength
- 20 mg
- Imprint
- MYLAN ZE 20 MYLAN ZE 20
- Color
- Blue & White
- Shape
- Capsule/Oblong

1 / 2
Loading
SANKYO C23
Hydrochlorothiazide and Olmesartan Medoxomil
- Strength
- 12.5 mg / 40 mg
- Imprint
- SANKYO C23
- Color
- Yellow
- Shape
- Oval

1 / 2
Loading
SANKYO C12

MYLAN MT 28 MYLAN MT 28
Memantine Hydrochloride Extended-Release
- Strength
- 28 mg
- Imprint
- MYLAN MT 28 MYLAN MT 28
- Color
- Green
- Shape
- Capsule/Oblong

MYLAN LL 2.5 MYLAN LL 2.5
Lenalidomide
- Strength
- 2.5 mg
- Imprint
- MYLAN LL 2.5 MYLAN LL 2.5
- Color
- Green & White
- Shape
- Capsule/Oblong

1 / 3
Loading
MYLAN 7250 MYLAN 7250
Cefaclor
- Strength
- 250 mg
- Imprint
- MYLAN 7250 MYLAN 7250
- Color
- Pink & White
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.